4//SEC Filing
Landis John B. 4
Accession 0001562180-21-004457
CIK 0001314102other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:30 PM ET
Size
7.7 KB
Accession
0001562180-21-004457
Insider Transaction Report
Form 4
Landis John B.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-22+11,000→ 11,000 totalExercise: $13.13From: 2022-02-09Exp: 2031-02-09→ Common Stock (11,000 underlying) - Award
Restricted Stock Units
2021-06-22+2,500→ 2,500 totalExercise: $0.00From: 2022-02-09→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]Will fully vest on the one-year anniversary of the grant date.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001477283
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 5:30 PM ET
- Size
- 7.7 KB